MENU
INMB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

INmune Bio (INMB) Ownership - Who owns INmune Bio?

INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
225 NE Mizner Boulevard
Phone
+1 561 710-0512
Employees
21
Web
https://www.inmunebio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
38.55M
P/E Ratio
N/A
Total Cash
21.36M
Projected Growth
N/A
Total Debt
1.51M
Revenue
N/A
Risk (Beta)
1.25
Dividend Yield
N/A
Total Cash/Share
0.80
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
INMB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of therapies that harness the patient's immune system to treat cancer

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
225 NE Mizner Boulevard
Phone
+1 561 710-0512
Employees
21
Web
https://www.inmunebio.com